Evidence map›Paper›PMID 42445816›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2026

Polarization-Sensitive OCT Assessment of Retinal Emboli in Branch Retinal Artery Occlusion: A Pilot Study.

Ryo Terao, Yuki Saeki, Kazuki Yashiro, Mami Ota, Shuichiro Aoki, Kohdai Kitamoto, Keiko Azuma

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ryo TeraoDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.ORCID 0000-0001-6182-4343
Yuki SaekiDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Kazuki YashiroDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Mami OtaDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Shuichiro AokiDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Kohdai KitamotoDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Keiko AzumaDepartment of Ophthalmology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate intraluminal emboli in branch retinal artery occlusion (BRAO) using polarization-sensitive optical coherence tomography (PS-OCT). Patients and Methods: Eight eyes of 8 patients with BRAO were included. Fundus photography, swept-source (SS)-OCT, and PS-OCT were performed. Detection rates and entropic profiles of retinal emboli were examined. Results: In this retrospective study of 8 BRAO eyes, fundus photography found thromboemboli in five eyes (62.5%). While SS-OCT detected thromboembolus in two eyes (25.0%), PS-OCT identified in all (100%) eyes, demonstrating a higher detection rate than SS-OCT. Polarimetric entropy (PE) value of thromboemboli was significantly higher than that of background retina ( Conclusion: PS-OCT enables noninvasive visualization of intraluminal embolic material and may provide additional pathophysiological insight beyond conventional OCT. However, these findings are based on a small retrospective cohort and require validation in larger prospective studies.

Indexed as

polarimetric entropypolarization-sensitive optical coherence tomographyretinal artery occlusionretinal ischemiathromboembolism

Identifiers

PMID42445816
PMCPMC13361341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.